Yahoo Web Search

Search results

1. • 'Chameleon' attacks drug-resistant brain cancers

     Futurity· 4 hours ago

     The research in the Journal of the American Chemical Society is a crucial step in the development of so-called “chameleon compounds” that may be used to target an array of pernicious cancers ...

2. • 

     Gaston 6-year-old to have the summer of her life while fighting cancer

     The Gaston Gazette via Yahoo News· 2 days ago

     A Gaston family is seeking solace in the community as six-year-old Harmony Nicholson’s months-long...

3. • 

     12-year-old beats rare brain cancer but after 3 years remission is now battling a new form of brain...

     WZZM 13 Grand Rapids· 2 days ago

     Nearly six years ago, now 12-year-old Emerson Hoogendoorn was diagnosed with diffuse midline glioma,...

4. • 

     Gene therapy offers huge potential for combating disease, doctors say

     UPI· 7 days ago

     1 of 3 | Dr. Krystof Bankiewicz collaborates with his team in the lab at The Ohio State University...

5. • 

     Community supports 12-year-old cancer patient who ‘beat the unbeatable’

     WOOD via Yahoo News· 3 days ago

     Emerson Hoogendoorn's loved ones say she can be described in many words: kind, strong, giving. But...

6. • 

     June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge

     InvestorPlace· 1 day ago

     Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the...

7. • 

     Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study

     Zacks via Yahoo Finance· 2 days ago

     Data from a late-stage study shows that transfusion-dependent thalassemia patients who received...

8. • 

     Walk six laps for Emerson the Brave, a 12-year-old battling cancer in Holland

     The Holland Sentinel via Yahoo News· 4 days ago

     The fundraiser runs 6-8 p.m. Tuesday, June 4, at the middle school stadium track — the old varsity...

9. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 5 days ago

     Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation PR Newswire TARRYTOWN, N.Y., June 1, 2024 -Data demonstrates durable responses across 3 cohorts of patients with

10. • 

      Letters | Arkansas Democrat Gazette

      Arkansas Democrat-Gazette· 7 days ago

      Trump repeatedly disparaged the intelligence of service members, asking that wounded veterans be kept out of military parades. It was amazing to see so...